Interleukin 17: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
'''Interleukin 17''' (IL-17) | == Interleukin 17 == | ||
[[File:IL17F_1JPY.png|thumb|right|Structure of Interleukin 17F]] | |||
'''Interleukin 17''' (IL-17) is a pro-inflammatory [[cytokine]] that plays a crucial role in the immune system. It is part of a family of cytokines known as the IL-17 family, which includes six members: IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (also known as IL-25), and IL-17F. These cytokines are produced by a variety of cells, including [[T helper 17 cells]] (Th17), a subset of [[CD4+ T cells]]. | |||
== Function == | == Function == | ||
Interleukin 17 is primarily involved in the regulation of [[immune response]]s, particularly in the defense against extracellular [[bacteria]] and [[fungi]]. It stimulates the production of other pro-inflammatory cytokines, such as [[tumor necrosis factor]] (TNF) and [[interleukin 6]] (IL-6), and promotes the recruitment of [[neutrophils]] to sites of infection. | |||
== IL-17 Family == | |||
The IL-17 family consists of six cytokines, each with distinct roles in immune regulation: | |||
* '''IL-17A''': The most studied member, involved in autoimmune diseases and chronic inflammatory conditions. | |||
* '''IL-17B''': Less understood, but implicated in inflammatory responses. | |||
* '''IL-17C''': Plays a role in epithelial cell responses to infection. | |||
* '''IL-17D''': Involved in the regulation of [[innate immunity]]. | |||
* '''IL-17E (IL-25)''': Promotes [[Th2 cell]] responses and is involved in allergic reactions. | |||
* '''IL-17F''': Similar to IL-17A, involved in mucosal immunity. | |||
== Clinical Significance == | |||
[[File:IL17F_1JPY.png|thumb|left|Another view of IL-17F structure]] | |||
IL-17 has been implicated in a variety of [[autoimmune diseases]], including [[rheumatoid arthritis]], [[psoriasis]], and [[multiple sclerosis]]. It is also associated with chronic inflammatory conditions such as [[inflammatory bowel disease]] (IBD). Targeting IL-17 with specific [[monoclonal antibodies]] has become a therapeutic strategy in treating these diseases. | |||
== Related Pages == | |||
* [[Cytokine]] | * [[Cytokine]] | ||
* [[T | * [[T helper 17 cells]] | ||
* [[ | * [[Autoimmune disease]] | ||
* [[ | * [[Inflammation]] | ||
[[Category: | {{Cytokines}} | ||
[[Category:Immunology]] | |||
[[Category:Cytokines]] | [[Category:Cytokines]] | ||
Latest revision as of 04:06, 13 February 2025
Interleukin 17[edit]

Interleukin 17 (IL-17) is a pro-inflammatory cytokine that plays a crucial role in the immune system. It is part of a family of cytokines known as the IL-17 family, which includes six members: IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (also known as IL-25), and IL-17F. These cytokines are produced by a variety of cells, including T helper 17 cells (Th17), a subset of CD4+ T cells.
Function[edit]
Interleukin 17 is primarily involved in the regulation of immune responses, particularly in the defense against extracellular bacteria and fungi. It stimulates the production of other pro-inflammatory cytokines, such as tumor necrosis factor (TNF) and interleukin 6 (IL-6), and promotes the recruitment of neutrophils to sites of infection.
IL-17 Family[edit]
The IL-17 family consists of six cytokines, each with distinct roles in immune regulation:
- IL-17A: The most studied member, involved in autoimmune diseases and chronic inflammatory conditions.
- IL-17B: Less understood, but implicated in inflammatory responses.
- IL-17C: Plays a role in epithelial cell responses to infection.
- IL-17D: Involved in the regulation of innate immunity.
- IL-17E (IL-25): Promotes Th2 cell responses and is involved in allergic reactions.
- IL-17F: Similar to IL-17A, involved in mucosal immunity.
Clinical Significance[edit]

IL-17 has been implicated in a variety of autoimmune diseases, including rheumatoid arthritis, psoriasis, and multiple sclerosis. It is also associated with chronic inflammatory conditions such as inflammatory bowel disease (IBD). Targeting IL-17 with specific monoclonal antibodies has become a therapeutic strategy in treating these diseases.
Related Pages[edit]
| Cell signaling: cytokines | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|